SEC Form 4/A · accession 0001077183-18-000071
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Douglas M Van Oort
Officer — Chairman and CEO · Director
Period of report
Aug 3, 2018
Accepted (ET)
Aug 3, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 3, 2018 | F | 21,904 | $0.00 | D | 2,008,123 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2018 vesting of restricted stock.
- F2This Amended Form 4 reflects the corrected presentation of the securities beneficially owned following the withholding of shares to satisfy tax obligations (noted in Footnote 1). This correction is the result of a restricted stock award granted on May 25, 2017 which was inadvertently classified in Table II and was moved to Table I on a Form 4/A filed on August 3, 2018 which amended the Form 4 originally filed on May 30, 2017.